Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.

Hoefen R, Reumann M, Goldenberg I, Moss AJ, O-Uchi J, Gu Y, McNitt S, Zareba W, Jons C, Kanters JK, Platonov PG, Shimizu W, Wilde AA, Rice JJ, Lopes CM.

J Am Coll Cardiol. 2012 Nov 20;60(21):2182-91. doi: 10.1016/j.jacc.2012.07.053.

2.

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

Jons C, Moss AJ, Lopes CM, McNitt S, Zareba W, Goldenberg I, Qi M, Wilde AA, Shimizu W, Kanters JK, Towbin JA, Ackerman MJ, Robinson JL.

J Cardiovasc Electrophysiol. 2009 Aug;20(8):859-65. doi: 10.1111/j.1540-8167.2009.01455.x. Epub 2009 Mar 13.

PMID:
19490272
3.

Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population.

Winbo A, Diamant UB, Stattin EL, Jensen SM, Rydberg A.

Circ Cardiovasc Genet. 2009 Dec;2(6):558-64. doi: 10.1161/CIRCGENETICS.108.825547. Epub 2009 Sep 14.

4.

Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.

Jons C, O-Uchi J, Moss AJ, Reumann M, Rice JJ, Goldenberg I, Zareba W, Wilde AA, Shimizu W, Kanters JK, McNitt S, Hofman N, Robinson JL, Lopes CM.

Sci Transl Med. 2011 Mar 30;3(76):76ra28. doi: 10.1126/scitranslmed.3001551.

5.

Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.

Diamant UB, Vahedi F, Winbo A, Rydberg A, Stattin EL, Jensen SM, Bergfeldt L.

J Appl Physiol (1985). 2013 Nov;115(10):1423-32. doi: 10.1152/japplphysiol.00665.2013. Epub 2013 Sep 19.

PMID:
24052033
6.

Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan.

Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, Washizuka T, Aizawa Y, Nakamura K, Ohe T, Aiba T, Miyamoto Y, Yoshimasa Y, Towbin JA, Priori SG, Kamakura S.

J Am Coll Cardiol. 2004 Jul 7;44(1):117-25.

7.

Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome.

Costa J, Lopes CM, Barsheshet A, Moss AJ, Migdalovich D, Ouellet G, McNitt S, Polonsky S, Robinson JL, Zareba W, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Goldenberg I.

Heart Rhythm. 2012 Jun;9(6):892-8. doi: 10.1016/j.hrthm.2012.01.020. Epub 2012 Jan 28.

8.

Long QT syndrome in adults.

Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, Robinson JL, Qi M, Goldenberg I, Hobbs JB, Ackerman MJ, Benhorin J, Hall WJ, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L.

J Am Coll Cardiol. 2007 Jan 23;49(3):329-37. Epub 2007 Jan 4.

9.

Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location.

Laksman ZW, Hamilton RM, Chockalingam P, Ballantyne E, Stephenson EA, Gross GJ, Gula LJ, Klein GJ, Wilde AA, Krahn AD.

J Cardiovasc Electrophysiol. 2013 Sep;24(9):1015-20. doi: 10.1111/jce.12172. Epub 2013 May 20.

PMID:
23691991
10.

Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals.

Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Platonov PG, Priori SG, Qi M, Schwartz PJ, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Zhang L.

J Am Coll Cardiol. 2011 Jan 4;57(1):51-9. doi: 10.1016/j.jacc.2010.07.038.

11.

Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.

Ruwald MH, Xu Parks X, Moss AJ, Zareba W, Baman J, McNitt S, Kanters JK, Shimizu W, Wilde AA, Jons C, Lopes CM.

Heart Rhythm. 2016 Jan;13(1):122-31. doi: 10.1016/j.hrthm.2015.08.033. Epub 2015 Aug 28.

12.

Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification.

Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, Benhorin J, Zhang L, Vincent GM, Andrews ML, Robinson JL, Morray B.

J Am Coll Cardiol. 2006 Sep 5;48(5):1047-52. Epub 2006 Jul 7.

13.
14.

Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome.

Extramiana F, Maison-Blanche P, Denjoy I, De Jode P, Messali A, Labbé JP, Leenhardt A.

Ann Noninvasive Electrocardiol. 2013 Jul;18(4):399-408. doi: 10.1111/anec.12048. Epub 2013 May 3.

PMID:
23879280
15.

Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome.

Mathias A, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Qi M, Shimizu W, Towbin JA, Michael Vincent G, Wilde AA, Zhang L, Goldenberg I.

Heart Rhythm. 2013 May;10(5):720-5. doi: 10.1016/j.hrthm.2013.01.032. Epub 2013 Jan 29.

PMID:
23369741
16.

T wave alternans in idiopathic long QT syndrome.

Zareba W, Moss AJ, le Cessie S, Hall WJ.

J Am Coll Cardiol. 1994 Jun;23(7):1541-6.

17.

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Zareba W, Moss AJ, Sheu G, Kaufman ES, Priori S, Vincent GM, Towbin JA, Benhorin J, Schwartz PJ, Napolitano C, Hall WJ, Keating MT, Qi M, Robinson J, Andrews ML; International LQTS Registry, University of Rochester, Rochester, New York.

J Cardiovasc Electrophysiol. 2003 Nov;14(11):1149-53.

PMID:
14678125
18.

Early repolarization is associated with symptoms in patients with type 1 and type 2 long QT syndrome.

Laksman ZW, Gula LJ, Saklani P, Cassagneau R, Steinberg C, Conacher S, Yee R, Skanes A, Leong-Sit P, Manlucu J, Klein GJ, Krahn AD.

Heart Rhythm. 2014 Sep;11(9):1632-8. doi: 10.1016/j.hrthm.2014.05.027. Epub 2014 May 24.

PMID:
24861447
19.

Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome.

Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, Wilde AA, McNitt S, Peterson DR, Zareba W, Robinson JL, Ackerman MJ, Cypress M, Gray DA, Hofman N, Kanters JK, Kaufman ES, Platonov PG, Qi M, Towbin JA, Vincent GM, Lopes CM.

Circulation. 2012 Apr 24;125(16):1988-96. doi: 10.1161/CIRCULATIONAHA.111.048041. Epub 2012 Mar 28.

20.

"QT clock" to improve detection of QT prolongation in long QT syndrome patients.

Page A, Aktas MK, Soyata T, Zareba W, Couderc JP.

Heart Rhythm. 2016 Jan;13(1):190-8. doi: 10.1016/j.hrthm.2015.08.037. Epub 2015 Aug 31.

Supplemental Content

Support Center